Conduit Pharmaceuticals Inc. has announced a virtual annual meeting of stockholders scheduled for December 18, 2024. The meeting will address the election of six directors, the ratification of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and a proposed amendment to authorize a reverse stock split of common stock shares. The reverse stock split ratio will be set by the Board within a range of 1-for-10 to 1-for-100. The meeting is exclusively virtual, with stockholders able to participate and vote during the live webcast by registering in advance. The record date for stockholder entitlement to notice and vote is October 25, 2024. The company has also filed a preliminary proxy statement with the SEC, detailing the agenda and providing information on how stockholders can vote their shares.

Conduit Pharmaceuticals Inc. has announced a virtual annual meeting of stockholders scheduled for December 18, 2024. The meeting will address the election of six directors, the ratification of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and a proposed amendment to authorize a reverse stock split of common stock shares. The reverse stock split ratio will be set by the Board within a range of 1-for-10 to 1-for-100. The meeting is exclusively virtual, with stockholders able to participate and vote during the live webcast by registering in advance. The record date for stockholder entitlement to notice and vote is October 25, 2024. The company has also filed a preliminary proxy statement with the SEC, detailing the agenda and providing information on how stockholders can vote their shares.